Towarzystwo Funduszy Inwestycyjnych PZU SA’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Buy
1,154
+70
+6% +$26K 0.13% 128
2026
Q1
$317K Sell
1,084
-197
-15% -$64.7K 0.11% 143
2025
Q4
$449K Hold
1,281
0.11% 109
2025
Q3
$414K Hold
1,281
0.1% 105
2025
Q2
$498K Buy
1,281
+8
+0.6% +$3.22K 0.14% 76
2025
Q1
$554K Hold
1,273
0.19% 62
2024
Q4
$470K Buy
1,273
+60
+5% +$25.1K 0.16% 56
2024
Q3
$631K Hold
1,213
0.23% 47
2024
Q2
$657K Sell
1,213
-40
-3% -$21.1K 0.25% 47
2024
Q1
$650K Hold
1,253
0.28% 46
2023
Q4
$591K Buy
+1,253
New +$579K 0.27% 45
2021
Q3
$456K Sell
1,223
-75
-6% -$28.5K 0.54% 31
2021
Q2
$496K Sell
1,298
-60
-4% -$22.9K 0.59% 28
2021
Q1
$487K Buy
1,358
+80
+6% +$25.7K 0.71% 25
2020
Q4
$410K Buy
+1,278
New +$392K 0.42% 35

Other funds holding ELV

Towarzystwo Funduszy Inwestycyjnych PZU SA's ELV Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Elevance Health (ELV) stake by 6.5% in Q2 2026, buying an estimated $26K and bringing the position to 1,154 shares worth $446K. The position accounts for 0.13% of the portfolio, ranked #128.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in ELV in Q4 2020 and has held it in 15 quarters since. The position peaked at $657K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 1,154 shares of Elevance Health worth $446K as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA bought 70 Elevance Health shares in Q2 2026, an estimated $26K.
  • Elevance Health made up 0.13% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #128 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Elevance Health in Q4 2020 and has held it in 15 quarters since.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's Elevance Health position peaked at $657K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.